ABPO
Abpro Holdings, Inc.
Set alert
0.44 USD +0.01 +2.11%
0.39 Day range 0.42
0.10 52-week range 7.04
- YTD
- -89.69%
- 1 year
- -92.59%
- Open
- 0.39
- Prev close
- 0.427
- Mkt cap
- 2.57M
- Vol
- 15.00K
- Avg vol
- 16.32K
- EPS
- 1.81
- P/E
- 0.24
More statistics
- Low
- 0.39
- High
- 0.42
Financials — quick view
ABPO Revenue — quarterly 0
ABPO Net income — quarterly -1.66M
ABPO EPS — quarterly -0.63
News
- Short Interest in Abpro Holdings Inc. (NASDAQ:ABP) Increases By 271.4%
- Abpro's Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
- Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
- Abpro (NASDAQ:ABP) Stock Price Up 0.2% – Still a Buy?
- Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers
- Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives
- Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager
- Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025
- Abpro Holdings Inc. (NASDAQ:ABP) Sees Large Decrease in Short Interest
- Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
Your note
Sign in to keep a note on ABPO — it syncs with the Stock Master app.